<DOC>
	<DOCNO>NCT02263690</DOCNO>
	<brief_summary>92 patient treatment intravitreal injection randomize 1 3 group : proparacaine 0.5 % drop ( Group Drops ) , proparacaine 0.5 % drops plus subconjunctival lidocaine ( Group SC ) , 2 % lidocaine gel ( Group Gel ) . Patients ask score pain experience use visual analogue scale ( VAS ) , scale 0 10 , immediately follow injection well 10 minute , 1 hour , 6 hour 24 hour . Patients also grade overall injection experience Excellent , Very Good , Fair , Poor Awful . The physician evaluate patient 's eye movement intravitreal injection three level : none minimal ( 0 ) , compromise injection ( 1 ) , compromise injection ( 2 ) .</brief_summary>
	<brief_title>Comparison Three Different Anesthetic Approaches Intravitreal Injections</brief_title>
	<detailed_description>This prospective , randomize , triple-armed trial compare effectiveness three different anesthetic approach intravitreal injection . Were include 92 consecutive patient schedule receive intravitreal injection bevacizumab ( Avastin , Genentech , Inc. ) one eye , June 2014 September 2014 , evaluate single center - Retina Clinic , Osasco , São Paulo , Brazil . The ophthalmologist ( CGA ) administer , anesthetic therapeutic , injection . A masked nurse collect patient assessment response mask statistician perform statistical analysis . The research follow tenet Declaration Helsinki approve Committee Ethics Research . All participant give write informed consent prior participation . Patients randomize 1 3 group injection : proparacaine 0.5 % drop ( Anestalcon® , Alcon Lab . Brasil Ltda , São Paulo , Brazil ) , ( Group Drops ) , proparacaine plus subconjunctival lidocaine 1 % ( Xylestesin® , Cristália , São Paulo , Brazil ) ( Group SC ) , 2 % lidocaine gel ( Xylestesin® , Cristália , São Paulo , Brazil ) ( Group Gel ) . A standardized method use prepare injection site disinfect skin use povidone iodine 10 % . Patients group Drops SC receive drop proparacaine 0.5 % receive drop povidone iodine 5 % . For patient Group Gel , gel place eye receive drop povidone iodine 5 % . Patients Group Drops receive second drop proparacaine 0.5 % , 5 minute drop povidone iodine 5 % . For patient Group SC , subconjunctival bleb anesthesia create inject 0.4 ml lidocaine 1 % subconjunctival space , posteriorly superotemporal limbus 30-gauge , 1/2-inch needle attach 1-ml syringe . After 5 minute drop povidone iodine 5 % , sterile field lid speculum place . The injection site measure caliper 3.5 mm 4.0 mm posterior superotemporal limbus , pseudophakic phakic eye , respectively . A 30-gauge 1/2-inch needle use inject 0.05 ml bevacizumab ( Avastin , Genentech , Inc. ) . After injection , mild pressure apply swabstick injection site reduce vitreous reflux subconjunctival hemorrhage another drop povidone iodine 5 % apply . Immediately follow injection , nurse , mask treatment , explain 100-mm visual analog scale ( VAS ) pain ( Figure 1 ) question patient ' level pain perceive injection . This assessment repeat 10 minute , 1 hour , 6 hour 24 hour later , without visualization prior response . Patients also ask grade overall experience injection procedure Excellent ( 5 ) , Very good ( 4 ) , Fair ( 3 ) , Poor ( 2 ) Awful ( 1 ) . The physician evaluated patient ' eye movement intravitreal injection three level : none minimal ( 0 ) , compromise injection ( 1 ) , compromise injection ( 2 ) . Complications occur procedure also record .</detailed_description>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Proxymetacaine</mesh_term>
	<mesh_term>Propoxycaine</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Povidone</mesh_term>
	<criteria>Age : 18 year old Indications injection include neovascular AMD , DME cystoid macular edema ( CME ) secondary RVO . Previous known allergic response topical anesthetic use . Previous intravitreal injection drug antiVEGF agent Previous par plana vitrectomy Anterior segment condition could affect pain sensation , conjunctival irritation , active conjunctivitis keratitis bullous keratopathy Patients use systemic analgesic sedative medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>